Company Filing History:
Years Active: 2022-2025
Title: Alan Epstein: Innovator in Cancer Therapy
Introduction
Alan Epstein is a prominent inventor based in Los Angeles, CA (US). He has made significant contributions to the field of cancer therapy through his innovative work in developing humanized anti-nuclear antibodies. With a total of 2 patents, his research focuses on enhancing the efficacy of cancer treatments.
Latest Patents
Epstein's latest patents include groundbreaking advancements in humanized monoclonal anti-nuclear antibodies. These antibodies exhibit enhanced binding affinity and tumor uptake, which are crucial for effective cancer therapy. Specifically, the antibodies are site-directed mutants of H-CDR3, demonstrating up to an 8-fold improvement in affinity compared to their non-humanized, non-mutated counterparts. This innovation allows for targeted delivery of immune modulators, immune effectors, and other therapeutic or diagnostic agents to tumor necrosis.
Career Highlights
Alan Epstein is associated with Cancer Therapeutics Laboratories, Inc., where he continues to push the boundaries of cancer treatment. His work is characterized by a commitment to improving patient outcomes through innovative therapeutic strategies.
Collaborations
Epstein collaborates with Peisheng Hu, contributing to the advancement of cancer therapies through their combined expertise.
Conclusion
Alan Epstein's contributions to cancer therapy through his patented innovations highlight the importance of targeted treatments in modern medicine. His work continues to inspire advancements in the field, paving the way for more effective cancer therapies.